Core Concept: In the wake of COVID-19, decentralized clinical trials move to center stage.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

25 citing papers in PubMed.

1. Safety of BI 1358894 in patients with major depressive disorder: Results and learnings from a phase II randomized decentralized clinical trial.Clinical and translational science · 2024
   Trial
2. Feasibility of remote interviews in assessing disease severity in patients with major depressive disorder: A pilot study.Neuropsychopharmacology reports · 2024
   Trial
3. Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms.Clinical and translational science · 2023
   Trial
4. Stakeholder-reported perspectives on decentralized clinical trials: A multi-country descriptive survey.Contemporary clinical trials communications · 2026
   Article
5. Feasibility of Home-Based Spirometry Monitoring as a Decentralized Clinical Trial Component in Patients with Chronic Obstructive Pulmonary Disease and Other Respiratory Diseases.Healthcare (Basel, Switzerland) · 2026
   Article
6. The Future is Local: the Role of Decentralised Clinical Trials in Patients with Advanced Cancer Receiving Palliative Care.Current treatment options in oncology · 2026
   Review
7. Longitudinal voice monitoring in a decentralized Bring Your Own Device trial for respiratory illness detection.NPJ digital medicine · 2025
   Article
8. Exploration of Using an Open-Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements.Clinical and translational science · 2025
   Article
9. Navigating Complexities In Randomized Trials: Insights From The EMERGE Trial Amidst Pandemic And Cybersecurity Threat.HRB open research · 2025
   Article
10. Key considerations for digital decentralised clinical trials from a feasibility study assessing pacing interventions for long COVID.Scientific reports · 2024
    Article
11. The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial Data.Therapeutic innovation & regulatory science · 2024
    Review
12. The landscape of decentralized clinical trials (DCTs): focusing on the FDA and EMA guidance.Translational and clinical pharmacology · 2024
    Article
13. Narrative review of telemedicine applications in decentralized research.Journal of clinical and translational science · 2024
    Review
14. Opportunities and challenges for decentralised clinical trials in sub-Saharan Africa: a qualitative study.BMJ open · 2023
    Article
15. "Click and mortar" opportunities for digitization and consumerism in trials.Contemporary clinical trials · 2023
    Article
16. Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and Deployment.Therapeutic innovation & regulatory science · 2023
    Article
17. Decentralised clinical trials: ethical opportunities and challenges.The Lancet. Digital health · 2023
    Review
18. Decentralized research technology use in multicenter clinical research studies based at U.S. academic research centers.Journal of clinical and translational science · 2023
    Article
19. Noise-induced hearing disorders: Clinical and investigational tools.The Journal of the Acoustical Society of America · 2023
    Article
20. How do study design features and participant characteristics influence willingness to participate in clinical trials? Results from a choice experiment.BMC medical research methodology · 2022
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as